Clinical Trial Update: A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-masked, crossover trial comparing moxaverine to placebo for ocular blood flow in ischemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia

Drugs mentioned

• Moxaverine (moxaverine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Ischemia | Phase 2 | Status: COMPLETED